Fora Capital, LLC Astrazeneca PLC Transaction History

Fora Capital, LLC

$1.19 Billion
Q1 2024

A detailed history of Fora Capital, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Fora Capital, LLC holds 22,238 shares of AZN stock, worth $1.71 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

22,238

Previous 101,069 78.0%

Holding current value

$1.71 Million

Previous $6.81 Million 77.87%

% of portfolio

0.13%

Previous 0.6%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 02, 2024	SELL	$61.03 - $69.57 $4.81 Million - $5.48 Million	-78,831 Reduced 78.0%	22,238 $1.51 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $4.12 Million - $4.61 Million	66,517 Added 192.51%	101,069 $6.81 Million
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $1.24 Million - $1.37 Million	19,161 Added 124.49%	34,552 $2.34 Million
Q2 2023 Aug 11, 2023	BUY	$69.91 - $75.81 $1.08 Million - $1.17 Million	15,391 New	15,391 $1.1 Million
Q4 2022 Feb 08, 2023	SELL	$54.21 - $70.44 $2.87 Million - $3.73 Million	-53,015 Reduced 84.63%	9,629 $652,000

Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $3.32 Million - $8.5 Million	62,644 New	62,644 $3.44 Million
Q1 2022 May 12, 2022	SELL	$55.72 - $67.12 $553,968 - $667,307	-9,942 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$54.02 - $63.83 $537,066 - $634,597	9,942 New	9,942 $579,000
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $361,867 - $464,382	-8,396 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$37.79 - $51.33 $1.15 Million - $1.56 Million	-30,388 Reduced 78.35%	8,396 $374,000
Q4 2019 Feb 14, 2020	BUY	$42.46 - $50.46 $1.65 Million - $1.96 Million	38,784 New	38,784 $1.93 Million

Others Institutions Holding AZN

# of Institutions

1,247

Shares Held

477M

Call Options Held

5.99M

Put Options Held

5.24M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $239B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fora Capital, LLC with notifications on news.

Account